05/02/2024
5:07 AM | Aurinia Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/02/2024
5:03 AM | Aurinia Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/20/2024
4:23 PM | Aurinia Pharmaceuticals (Subject)
ILJIN SNT Co., Ltd. (Filed by)
| Form SC 13D/A | |
03/07/2024
3:44 PM | Aurinia Pharmaceuticals (Issuer)
Miller Joseph M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
3:46 PM | Aurinia Pharmaceuticals (Issuer)
Greenleaf Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
3:41 PM | Aurinia Pharmaceuticals (Issuer)
Robertson Stephen P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
3:42 PM | Aurinia Pharmaceuticals (Issuer)
Habig Scott Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/07/2024
3:43 PM | Aurinia Pharmaceuticals (Issuer)
Donley Matthew Maxwell (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
3:10 PM | Aurinia Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/29/2024
3:11 PM | Aurinia Pharmaceuticals (Issuer)
Knappertz Volker (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
3:31 PM | Aurinia Pharmaceuticals (Issuer)
Donley Matthew Maxwell (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
3:33 PM | Aurinia Pharmaceuticals (Issuer)
Habig Scott Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
3:35 PM | Aurinia Pharmaceuticals (Issuer)
Knappertz Volker (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
3:17 PM | Aurinia Pharmaceuticals (Issuer)
Miller Joseph M (Reporting)
| Form 4/A | |
02/22/2024
3:19 PM | Aurinia Pharmaceuticals (Issuer)
Robertson Stephen P. (Reporting)
| Form 4/A | |
02/15/2024
5:06 AM | Aurinia Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/15/2024
5:16 AM | Aurinia Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2024
2:27 PM | ARMISTICE CAPITAL, LLC (Filed by)
Aurinia Pharmaceuticals (Subject)
| Form SC 13G | |
02/12/2024
8:41 AM | Aurinia Pharmaceuticals (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A | |
01/05/2024
5:02 AM | Aurinia Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/02/2023
5:01 AM | Aurinia Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/02/2023
5:05 AM | Aurinia Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
09/22/2023
3:36 PM | Aurinia Pharmaceuticals (Issuer)
Foster Robert T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/22/2023
3:31 PM | Aurinia Pharmaceuticals (Issuer)
Foster Robert T (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/21/2023
3:06 PM | Aurinia Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/21/2023
3:16 PM | Aurinia Pharmaceuticals (Issuer)
Smith Karen L. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/21/2023
3:19 PM | Aurinia Pharmaceuticals (Issuer)
Smith Karen L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2023
3:21 PM | Aurinia Pharmaceuticals (Issuer)
Bailey Jeffrey Allen (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/21/2023
3:25 PM | Aurinia Pharmaceuticals (Issuer)
Bailey Jeffrey Allen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/03/2023
5:03 AM | Aurinia Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/03/2023
5:07 AM | Aurinia Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/06/2023
7:33 AM | Aurinia Pharmaceuticals (Subject)
MKT Capital Ltd. (Filed by)
| Form PX14A6G | |
07/03/2023
5:06 AM | Aurinia Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/01/2023
1:01 PM | Aurinia Pharmaceuticals (Subject)
MKT Capital Ltd. (Filed by)
| Form PX14A6G | |
05/26/2023
3:39 PM | Aurinia Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/23/2023
4:14 PM | Aurinia Pharmaceuticals (Issuer)
Leversage Jill (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2023
4:16 PM | Aurinia Pharmaceuticals (Issuer)
MacKay-Dunn R. Hector (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2023
4:16 PM | Aurinia Pharmaceuticals (Issuer)
MILNE GEORGE M JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2023
4:17 PM | Aurinia Pharmaceuticals (Issuer)
Billen Daniel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2023
4:18 PM | Aurinia Pharmaceuticals (Issuer)
Hagan Joseph P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2023
4:19 PM | Aurinia Pharmaceuticals (Issuer)
Jayne David R.W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
The AI stock to buy right now (Ad) There are about 350,000 large corporations worldwide.
Can you see the potential for this AI company to grow like crazy? Click Here to Get the AI Stock Name |
05/23/2023
4:22 PM | Aurinia Pharmaceuticals (Issuer)
Balakrishnan Brinda (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2023
3:00 PM | Aurinia Pharmaceuticals (Subject)
MKT Capital Ltd. (Filed by)
| Form PX14A6G | |
05/11/2023
10:34 AM | Aurinia Pharmaceuticals (Subject)
MKT Capital Ltd. (Filed by)
| Form PX14A6G | |
05/10/2023
3:30 PM | Aurinia Pharmaceuticals (Subject)
ILJIN SNT Co., Ltd. (Filed by)
| Form SC 13D/A | |
05/05/2023
10:17 AM | Aurinia Pharmaceuticals (Subject)
MKT Capital Ltd. (Filed by)
| Form PX14A6G | |
05/04/2023
5:06 AM | Aurinia Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/04/2023
5:10 AM | Aurinia Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/03/2023
1:53 PM | Aurinia Pharmaceuticals (Subject)
MKT Capital Ltd. (Filed by)
| Form PX14A6G | |
